Clinical Trials Logo

Body Weight clinical trials

View clinical trials related to Body Weight.

Filter by:

NCT ID: NCT04194424 Recruiting - Obesity Clinical Trials

A Multidisciplinary Weight Loss Program at AUB-MC

Start date: June 17, 2019
Phase: N/A
Study type: Interventional

The current project aims at evaluating the feasibility and efficacy of a multi-disciplinary weight loss program, using an innovative and simple dietary intervention at the American University of Beirut Medical Center (AUB-MC). Such intervention is expected to enhance patients' compliance and adherence to lifestyle changes. In addition, the program includes supervised exercise sessions and behavioral therapy. Therefore, our project proposes an evidence based approach to close the obesity treatment gaps.

NCT ID: NCT04193995 Recruiting - Weight Loss Clinical Trials

Intermittent Fasting as a Means to Lose Fluid Overload and Weight in Complicated Obesity

Start date: April 1, 2019
Phase: N/A
Study type: Interventional

To examine the feasibility of intermittent fasting (36h, twice a week, unlimited salt and calorie-free fluid consumption), over three months, on body weight and composition in complicated obesity in whom age and medical complexity exclude the possibility of bariatric surgery.

NCT ID: NCT04149756 Recruiting - Weight Reduction Clinical Trials

Persistent Weight Maintenance for 6 Months After 3 Months of Active Weight Loss

Start date: April 17, 2019
Phase:
Study type: Observational

This study is intended to report changes in the weight and metabolic indicators of the subjects six months after the end of the study for adults with a risk factor of 27 kg/m2 or higher (formerly the research task name[clinicaltrial.gov;NCT03675191]).

NCT ID: NCT04143074 Recruiting - Obesity Clinical Trials

Community Based Obesity Prevention and Treatment Programme "6-10-14 for Health"

Start date: April 1, 2011
Phase: N/A
Study type: Interventional

"6-10-14 for Health" is an integrated weight-loss intervention programme for obese children from Gdansk municipality. Both participants of the programme and their family members are offered a 12-month integrated intervention, including medical, dietetic and psychological counselling, as well as educational workshops for parents.

NCT ID: NCT04122209 Recruiting - Weight Loss Clinical Trials

Does the Timing of When High Intensity Intermittent Exercise is Undertaken Matter?

HIIE
Start date: October 16, 2019
Phase: N/A
Study type: Interventional

The participants will visit the laboratory on 3 occasions, once for a preliminary visit and a further two occasions to complete experimental trials in a randomised order. The experimental trials will consist of cycling under two conditions; HIIE-First followed by Continuous (Trial-A) or Continuous-First followed by HIIE (Trial-B). Participants will be asked to standardise their diet for 24-hours and complete an overnight fast prior to visiting the laboratory. Participants will then complete 60-min of cycling split throughout the day into two 30-min bouts, HIIE or continuous cycling before breakfast followed by a 3.5 hour rest period before completing their remaining 30-min HIIE or Continuous cycling before lunch. Each experimental trail will last approximately 8 hours and begin at 08:00am. Throughout the trial measurements of subjective feelings of appetite, gastric emptying rate, substrate utilisation and regular blood samples will be taken. Post-trial nutritional and well-being questionnaires will be collected at 24-h post. Study hypothesis 1. The order in which continuous and HIIE is undertaken will result in differences in gastric emptying rate after ingesting a semi-sold lunch? 2. Depending on which mode of exercise is undertaken first will result in different gastrointestinal hormone responses, metabolic responses and appetite responses throughout the trial day? 3. Will the order in which different modes of exercise, undertaken within the same day effect nutritional intake and well-being 24-h after both exercise bout have been completed? 4. Is substrate oxidation effected by the order in which multiple exercise bout of different modes are undertaken within the same day.

NCT ID: NCT03920787 Recruiting - Insulin Resistance Clinical Trials

Evaluating the Effect of Inositol Supplementation in Overweight Children on Basal Insulin and Body Weight

Start date: March 10, 2018
Phase: N/A
Study type: Interventional

Inositol in involved in the insulin pathway. In literature it has been demonstrated to improve insulin sensitivity and ovarian function in women affected by PCOS. In a preliminary study conducted on obese children between 7 and 15 years, the investigators have demonstrated that Inositol administration (Myo-inositol 1100 mg + D-Chiro-inositol 27,6 mg + Folic Acid 400 μg) before a Glucose Oral Tolerance Test reduces the increase of insulin levels, particularly in subjects with basal insulin ≥ 15 uU/ml. So the aim of this study is to evaluate the potential therapeutic effect of inositol, as non-pharmacologic agent, in preventing tipe II diabetes in children.

NCT ID: NCT03917758 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

GliRACo1
Start date: October 10, 2018
Phase: N/A
Study type: Interventional

Subjects treated with Canagliflozin, Dapagliflozin and Empagliflozin obtained improvement on blood pressure values, body weight and cardiovascular mortality but pathophysiological explanations of these effects are not yet known.

NCT ID: NCT03916354 Recruiting - Pregnancy Clinical Trials

Maternal Gestational Weight Gain and Microbiota of Maternal and Infant

Start date: May 7, 2019
Phase:
Study type: Observational [Patient Registry]

A prospective, multicenter, observational cohort study including about 550 mother-infant pairs in Beijing will be conducted to evaluate the association between mothers' gestational weight gain and the gut microbiota of them and their infants.

NCT ID: NCT03915392 Recruiting - Cholesteatoma Clinical Trials

Diffusion Weighted MRI Accuracy in Cholesteatoma Localization

CHOLEMRI
Start date: July 1, 2018
Phase:
Study type: Observational

Magnetic resonance imaging of the middle ear has an increasing place in the therapeutic strategy in otology and especially for cholesteatoma. It is currently performed for complicated cholesteatomas and as part of the follow-up of operated patients to detect a recurrence or a cholesteatoma residue (alternative of choice to "second look" surgery). Some people take CT and MRI fusion to improve the localization of cholesteatoma. Many studies have investigated the diagnostic capabilities of MRI but very few have demonstrate their reliability in location diagnosis. The aim of the study was to propose a topographic reading method of the MRI of the middle ear and to evaluate the performances in the localization of the cholesteatoma in order to adapt the surgical management

NCT ID: NCT03876704 Recruiting - Sepsis Clinical Trials

Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants

Start date: January 29, 2019
Phase: Phase 3
Study type: Interventional

Vitamins A, D, and E play important roles in humans, such as vision function, immune function, bone metabolism, cell growth and differentiation and oxidation resistance. Deficiencies in these vitamins will result in a high prevalence of cardiovascular disease, infection, bone diseases, etc. Preterm infants, especially very low birth weight infants, are at risk of vitamin deficiency. Intravenous perfusion is the most common and widely used method to supply vitamins for the specific population in early life. However, the current dose of vitamin supplied by intravenous perfusion whether can meet the need of growth and development is not sure and the appropriate dose for preterm infants is still uncertain. The purpose of this study is to investigate whether current dose of fat-soluble vitamin supplementation is enough for very low birth weight infants, the safety of high dose of fat-soluble vitamin supplementation, and compare the differences of prevalence of common complications, such as bronchopulmonary dysplasia, patent ductus arteriosus, sepsis, anemia, and neural development between these two groups.